Hermetica Superfood Encyclopedia
The Short Answer
Pourouma cecropiifolia fruit contains phenolic bioactives—principally epicatechin, caffeic acid, chlorogenic acid isomers, procyanidin B2, nortracheloside, and trans-resveratrol—that exert antioxidant activity via ROS scavenging and inhibit cancer-associated cytochrome P450 enzymes CYP1A1 and CYP1B1 through direct molecular docking interactions. Seed hydroethanolic extracts demonstrate the most potent bioactivity, showing cytotoxicity against MCF-7 breast cancer cells at 50.6 μg GAE/mL in vitro and reducing artesunate IC₅₀ against Plasmodium falciparum by 85% at 10 μg GAE/mL, though no human clinical trials have yet been conducted.
CategoryFruit
GroupAmazonian
Evidence LevelPreliminary
Primary KeywordPourouma cecropiifolia benefits
Mapati — botanical close-up
Health Benefits
**Antioxidant Protection**
Seed extracts exhibit the strongest free-radical scavenging capacity as measured by DPPH, FRAP, and HRSA assays, with seed tissue containing 23.18 ± 0.04 mg GAE g⁻¹ total phenolics (dry weight), driven by high concentrations of procyanidin B2, caffeic acid, and chlorogenic acid isomers.
**Anticancer Potential**
In vitro antiproliferative activity has been recorded against MCF-7 breast cancer cells, HeLa cervical cancer cells, RKO colorectal cells, and T47D breast cancer cells; seed and peel extracts show cytotoxic thresholds of 50.6 and 104 μg GAE/mL, respectively, attributed to CYP1A1/CYP1B1 enzyme inhibition by epicatechin, caffeic acid, and nortracheloside.
**Genoprotective Activity**: At concentrations of 12
5–20 μg GAE/mL, hydroethanolic extracts significantly reduced DNA strand fragmentation and chromosomal aberrations in cell-based genotoxicity assays, suggesting antimutagenic capacity linked to phenolic antioxidant content.
**Antimalarial Activity**
Peel and seed extracts display activity against both chloroquine-sensitive (3D7) and chloroquine-resistant (W2) strains of Plasmodium falciparum in vitro, with seed extract potentiating artesunate efficacy by reducing its IC₅₀ by 85% at 10 μg GAE/mL, indicative of synergistic antimalarial properties.
**Anti-inflammatory Potential**
Quercetin glycosides and caffeic acid present in peel and seed fractions are structurally associated with NF-κB pathway modulation and cyclooxygenase inhibition in related species, though direct anti-inflammatory assays in Pourouma cecropiifolia remain to be published.
**Cardiovascular Bioactive Profile**: The peel contains 21
00 ± 0.30 µg g⁻¹ trans-resveratrol and 8.43 ± 0.04 mg g⁻¹ anthocyanins, compounds widely associated with endothelial protection and platelet aggregation inhibition in the broader phytochemical literature, though species-specific cardiovascular data are not yet available.
**Vitamin C and Micronutrient Contribution**: Peel tissue provides 4
67 ± 0.28 mg ascorbic acid per 100 g (dry weight), contributing to dietary antioxidant intake, while the seed fraction's dense polyphenol matrix may enhance iron absorption and modulate oxidative stress in erythrocytes, as suggested by hemolysis-protective data from HRSA assays.
Origin & History
Natural habitat
Pourouma cecropiifolia is a dioecious tree native to the western Amazon basin, distributed across Peru, Colombia, Ecuador, and Brazil, where it thrives in humid tropical lowland forests at elevations below 1,000 meters. The species belongs to the family Urticaceae and produces grape-like clusters of dark-purple fruit colloquially called 'uva caimarona' or mapati, harvested from semi-domesticated trees maintained by indigenous communities. It grows in rich alluvial soils along riverbanks and forest edges, and is occasionally cultivated in home gardens and agroforestry systems throughout Amazonia.
“Pourouma cecropiifolia has been cultivated and harvested by indigenous Amazonian communities—including groups in the Peruvian and Colombian Amazon—primarily as a food crop, with the sweet, grape-flavored fruit consumed fresh or fermented into traditional beverages during seasonal harvests. The tree holds cultural significance as a managed species in Amazonian agroforestry systems, where it is propagated from seed or cuttings and integrated into multi-strata home gardens ('chacras') alongside other native fruit trees. Detailed ethnopharmacological records specifically documenting its use as a medicinal plant are sparse in the peer-reviewed literature, though related Pourouma and Cecropia species within Urticaceae have documented traditional uses for anti-inflammatory and antimalarial preparations across the Amazon basin. Modern scientific interest has shifted focus toward systematic bioprospecting of the fruit fractions using advanced analytical platforms (UPLC-QTOF-MS, HPLC-DAD), moving beyond traditional food use to explore pharmaceutical and nutraceutical potential.”Traditional Medicine
Scientific Research
The current evidence base for Pourouma cecropiifolia is limited exclusively to in vitro cell-based studies and in silico computational modeling, with no published human clinical trials, animal intervention studies, or pharmacokinetic data identified as of the most recent literature review. Key published work includes UPLC-QTOF-MS phytochemical profiling of hydroethanolic peel, pulp, and seed extracts; DPPH/FRAP/HRSA antioxidant assays; antiproliferative MTT assays against five cancer cell lines (A549, MCF-7, HeLa, RKO, T47D); Plasmodium falciparum 3D7/W2 in vitro antimalarial screens; and Ames-type genotoxicity/antigenotoxicity assays. Molecular docking computations provide mechanistic hypotheses for CYP1A1/CYP1B1 inhibition but have not been validated by biochemical enzyme assays or cell-based CYP reporter systems. The overall evidence quality is preliminary: findings are hypothesis-generating rather than confirmatory, effect magnitudes are reported only at fixed extract concentrations without dose-response modeling, and the absence of bioavailability data makes translation to physiological relevance highly uncertain.
Preparation & Dosage
Traditional preparation
**Hydroethanolic Extract (Research Grade)**
Concentrations of 12.5–104 μg GAE/mL have been used in cell-based studies; no equivalent human oral dose has been established, and these figures reflect in vitro test concentrations only.
**Fresh Fruit (Traditional Consumption)**
The ripe fruit is consumed fresh in Amazonian communities, typically eating the pulp directly or preparing fermented beverages; no standardized intake quantity has been documented in ethnobotanical literature.
**Seed Fraction**
18 mg GAE g⁻¹ d
Seeds contain the highest phenolic density (23..w.) and strongest bioactivity in vitro; however, seeds are not consumed as food in traditional practice and no safe oral preparation method has been validated.
**Peel Extract**
43 mg g⁻¹) concentrations; again, no oral supplement form or standardized extract is commercially available
Peel provides peak trans-resveratrol (21.00 µg g⁻¹) and anthocyanin (8..
**No Commercial Supplement Form Exists**
As of current literature, Pourouma cecropiifolia is not available as a standardized commercial dietary supplement (capsule, powder, tincture, or standardized extract), and no evidence-based dosing guideline can be provided.
Nutritional Profile
The pulp of Pourouma cecropiifolia contains modest total phenolics (0.30 ± 0.01 mg GAE g⁻¹ d.w.) and low flavonoids (0.03 ± 0.00 mg QE g⁻¹), with a small anthocyanin fraction (0.16 mg g⁻¹) and 2.60 µg g⁻¹ trans-resveratrol; ascorbic acid is absent in the pulp but present in the peel (4.67 ± 0.28 mg 100 g⁻¹ d.w.). The peel is nutritionally distinguished by high anthocyanin content (8.43 ± 0.04 mg g⁻¹), the highest trans-resveratrol concentration across all fruit parts (21.00 ± 0.30 µg g⁻¹), and measurable flavonoids (0.13 ± 0.00 mg QE g⁻¹). The seed fraction is phytochemically richest, with 23.18 ± 0.04 mg GAE g⁻¹ total phenolics, 0.31 ± 0.00 mg QE g⁻¹ flavonoids, and 1.80 mg g⁻¹ anthocyanins; however, seeds are not a typical dietary component. Identified phytochemicals include epicatechin, quercetin glycosides, caffeic acid, chlorogenic acid isomers, neoolivil (a lignan), procyanidin B2, nortracheloside (an iridoid glycoside), terpene derivatives, curcuminoids, and naphthodianthrone; standard macronutrient composition (carbohydrates, protein, fat, fiber) has not been formally published, and bioavailability data for any constituent are absent.
How It Works
Mechanism of Action
The dominant mechanistic pathway identified involves direct inhibition of aryl hydrocarbon receptor-regulated cytochrome P450 enzymes implicated in carcinogen bioactivation: in silico molecular docking studies reveal caffeic acid binds CYP1A1 with a binding energy of -10.7 kcal mol⁻¹, epicatechin binds CYP1B1 at -10.3 kcal mol⁻¹, and nortracheloside binds CYP1A1 at -9.2 kcal mol⁻¹, suggesting competitive inhibition that may reduce metabolic activation of procarcinogens. Antioxidant mechanisms operate through direct hydrogen atom transfer and electron donation by polyphenols—particularly procyanidin B2 and chlorogenic acid—to neutralize reactive oxygen species (ROS), as validated by significant reductions in intracellular ROS in A549 lung cancer cells and protective effects on human erythrocyte membrane integrity in HRSA assays. Antimalarial activity appears to operate via a synergistic mechanism with artesunate, where seed phenolics may interfere with heme detoxification pathways in Plasmodium falciparum or inhibit parasite-specific efflux pumps, effectively re-sensitizing resistant W2 strains; the 85% reduction in artesunate IC₅₀ at 10 μg GAE/mL supports a pharmacodynamic potentiation model. Genoprotective effects are attributed to the combined antioxidant suppression of oxidative DNA damage and potential modulation of phase II detoxification enzymes, reducing chromosomal aberration rates and DNA fragmentation at sub-cytotoxic concentrations (12.5–20 μg GAE/mL).
Clinical Evidence
No human clinical trials investigating Pourouma cecropiifolia have been identified in any published literature or registered clinical trial databases. All efficacy data derive from cell culture experiments using defined cancer cell lines and Plasmodium falciparum cultures, supplemented by computational docking studies; these experimental models provide mechanistic plausibility but cannot establish clinical efficacy, optimal dosing, or human safety. Effect sizes such as the 85% reduction in artesunate IC₅₀ and cytotoxic activity at 50.6 μg GAE/mL are meaningful in vitro benchmarks but lack corresponding pharmacokinetic context to determine whether similar concentrations are achievable in human plasma or target tissues. Confidence in any therapeutic claim must therefore remain very low pending at minimum in vivo animal studies, bioavailability characterization, and ultimately randomized controlled trials in human populations.
Safety & Interactions
No human safety data, adverse event reports, maximum tolerated doses, or formal toxicological studies have been published for Pourouma cecropiifolia extracts or fruit fractions; the complete absence of in vivo and clinical safety evaluation means that the risk profile in humans is entirely unknown. In vitro antigenotoxic and antimutagenic activity at 12.5–20 μg GAE/mL suggests the extract does not appear mutagenic at these concentrations in cell-based assays, but this does not constitute evidence of systemic safety in humans. No documented drug interactions exist, though the presence of caffeic acid and quercetin glycosides raises theoretical concerns regarding interactions with cytochrome P450-metabolized drugs (particularly CYP1A2 substrates such as theophylline and certain chemotherapeutics) given the demonstrated in silico CYP1A1 inhibitory activity. Guidance for use during pregnancy, lactation, or in pediatric populations cannot be provided given the complete absence of relevant data, and consumption beyond traditional food use of the fresh fruit is not advisable without further safety characterization.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Pourouma cecropiifolia Mart.mapatiuva caimaronauva de monteAmazon grape
Frequently Asked Questions
What are the main bioactive compounds in Pourouma cecropiifolia?
Hydroethanolic extracts of Pourouma cecropiifolia contain 18 tentatively identified compounds including epicatechin, quercetin glycosides, caffeic acid, chlorogenic acid isomers, procyanidin B2, nortracheloside (an iridoid glycoside), neoolivil (a lignan), and trans-resveratrol. The seed fraction is the most phenolic-dense part of the fruit at 23.18 mg GAE g⁻¹ dry weight, while the peel contains the highest concentrations of anthocyanins (8.43 mg g⁻¹) and trans-resveratrol (21.00 µg g⁻¹).
Does Pourouma cecropiifolia have anticancer properties?
In vitro studies have demonstrated antiproliferative activity against MCF-7 breast cancer, HeLa cervical, RKO colorectal, T47D breast, and A549 lung cancer cell lines, with cytotoxic thresholds of 50.6 μg GAE/mL for seeds and 104 μg GAE/mL for peel. The proposed mechanism involves inhibition of carcinogen-activating enzymes CYP1A1 and CYP1B1, supported by molecular docking calculations showing caffeic acid binding at -10.7 kcal mol⁻¹; however, no animal studies or human clinical trials have been conducted, so anticancer claims cannot be made for humans.
Is Pourouma cecropiifolia effective against malaria?
Seed and peel hydroethanolic extracts show in vitro activity against both the chloroquine-sensitive 3D7 and chloroquine-resistant W2 strains of Plasmodium falciparum. Most notably, seed extract reduced the IC₅₀ of artesunate by 85% at a concentration of 10 μg GAE/mL, suggesting potent pharmacodynamic synergy; however, these findings are entirely preclinical and have not been tested in animal models or human malaria patients.
Are there any clinical trials or human studies on mapati fruit?
No human clinical trials, observational studies, or pharmacokinetic studies involving Pourouma cecropiifolia have been published in the peer-reviewed literature as of the most recent search. All available evidence comes from in vitro cell-line experiments and in silico computational docking studies, which provide mechanistic hypotheses but do not establish clinical efficacy, safe dosing, or bioavailability in humans.
What is the safe dose of Pourouma cecropiifolia extract?
No safe human dose has been established for any extract or supplement form of Pourouma cecropiifolia, as no formal toxicological studies, dose-escalation trials, or pharmacokinetic studies in humans or animals have been conducted. Research concentrations used in cell studies range from 12.5 to 104 μg GAE/mL in vitro, but these figures cannot be directly translated into oral doses without bioavailability data; consuming the fresh fruit in traditional Amazonian dietary quantities is the only form of use with any historical precedent.
Which part of Pourouma cecropiifolia (mapati) fruit has the highest antioxidant content?
The seeds of mapati fruit contain the strongest antioxidant capacity, with seed extracts demonstrating superior free-radical scavenging ability across multiple assays (DPPH, FRAP, and HRSA). Seed tissue contains approximately 23.18 ± 0.04 mg GAE g⁻¹ of total phenolics on a dry weight basis, substantially outperforming other fruit tissues. This high antioxidant potency is primarily driven by elevated concentrations of procyanidin B2, caffeic acid, and chlorogenic acid isomers found in the seed.
Is mapati fruit (Pourouma cecropiifolia) better absorbed as a whole fruit, extract, or powder supplement?
While mapati is traditionally consumed as a whole fruit in Amazonian regions, seed extracts appear to concentrate the bioactive compounds responsible for antioxidant activity, potentially offering greater efficacy per serving than whole fruit alone. Standardized extracts ensure consistent levels of key phenolic compounds such as procyanidin B2 and chlorogenic acid isomers, which may enhance bioavailability compared to variable whole-fruit consumption. However, whole-fruit consumption provides fiber and additional phytonutrients that extracts may lack, so the optimal form depends on individual health goals.
Who should consider mapati (Pourouma cecropiifolia) supplementation for antioxidant support?
Individuals seeking enhanced antioxidant protection may benefit from mapati, particularly those with high oxidative stress from environmental exposure, aging, or chronic inflammation, given the fruit's notably high phenolic content and strong free-radical scavenging capacity. People interested in supporting cellular health and potentially reducing cancer risk may find value in mapati's demonstrated in vitro antiproliferative activity, though human evidence remains limited. Those already consuming polyphenol-rich diets (berries, tea, dark chocolate) should weigh whether additional mapati supplementation provides meaningful incremental antioxidant benefit.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w mapati-pourouma-cecropiifolia curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
